Richardson Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$384 Sell
8
-11
-58% -$473 ﹤0.01% 595
2026
Q1
$698 Hold
19
﹤0.01% 583
2025
Q4
$1.14K Buy
19
+7
+58% +$358 ﹤0.01% 555
2025
Q3
$666 Sell
12
-174
-94% -$10.2K ﹤0.01% 493
2025
Q2
$13K Sell
186
-1,827
-91% -$124K 0.01% 377
2025
Q1
$140K Sell
2,013
-4
-0.2% -$330 0.11% 166
2024
Q4
$173K Sell
2,017
-995
-33% -$108K 0.12% 152
2024
Q3
$429K Buy
3,012
+37
+1% +$4.93K 0.27% 92
2024
Q2
$425K Buy
2,975
+228
+8% +$30.2K 0.31% 88
2024
Q1
$353K Buy
2,747
+2,378
+644% +$283K 0.25% 101
2023
Q4
$38.2K Buy
+369
New +$36.5K 0.03% 234

Other funds holding NVO

Richardson Financial Services's NVO Position: Q2 2026 in Review

Richardson Financial Services reduced its Novo Nordisk (NVO) stake by 58% in Q2 2026, selling an estimated $473 and leaving 8 shares worth $384. The position accounts for ﹤0.01% of the portfolio, ranked #595.

Richardson Financial Services first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $429K in Q3 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Richardson Financial Services held 8 shares of Novo Nordisk worth $384 as of Q2 2026.
  • Richardson Financial Services sold 11 Novo Nordisk shares in Q2 2026, an estimated $473.
  • Novo Nordisk made up ﹤0.01% of Richardson Financial Services's portfolio in Q2 2026, its #595 holding.
  • Richardson Financial Services first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Richardson Financial Services's Novo Nordisk position peaked at $429K in Q3 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Richardson Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.